Home › Funds › Measured Wealth Private Client Group, LLC › XPH

Measured Wealth Private Client Group, LLC position in XPH

SPDR S&P PHARMA ETF

Measured Wealth Private Client Group, LLC reported holding 66,589 shares of XPH (SPDR S&P PHARMA ETF) in its Q3 2026 13F filing — a position valued at US$4.3M, representing 1.09% of its reported portfolio and ranking #25 among its reported holdings. Measured Wealth Private Client Group, LLC has disclosed XPH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)66.59K sh
Reported value held$4.33M
Portfolio Weight1.09%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Measured Wealth Private Client Group, LLC's XPH position evolved

Measured Wealth Private Client Group, LLC first disclosed a stake in XPH in Q2 2026 at 68,306 shares (US$4.5M). Across 2 filings, Measured Wealth Private Client Group, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 66,589 shares valued at US$4.3M — a reduction of -1,717 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 68.31K $4.53M New
Q3 2026 66.59K $4.33M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XPH and 13F data

XPH (SPDR S&P PHARMA ETF) is a company whose sector is not yet classified in our data. 40 other funds we track also report a position in XPH — the largest reported positions include Parkway Wealth Management Group, LLC (US$24.8M), Uniting Wealth Partners, LLC (US$4.4M), Braeburn Wealth Management LLC (US$2.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XPH

All XPH fund holders →

FAQ

How long has Measured Wealth Private Client Group, LLC held XPH?

Measured Wealth Private Client Group, LLC has disclosed XPH holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Measured Wealth Private Client Group, LLC's current position in XPH?

As of Q3 2026, Measured Wealth Private Client Group, LLC holds 66.59K shares of XPH (SPDR S&P PHARMA ETF), valued at $4.33M, representing 1.09% of its reported portfolio and ranking #25.

Has Measured Wealth Private Client Group, LLC been buying or selling XPH?

In the latest 13F filing (Q3 2026), Measured Wealth Private Client Group, LLC reduced its position in XPH.

Which other funds hold XPH?

Other major institutional holders of XPH include Parkway Wealth Management Group, LLC, Uniting Wealth Partners, LLC, Braeburn Wealth Management LLC, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.